Kromek Group completes fundraising of £1.7 million

Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, has announced that it has completed a fundraising of £1.7 million through the issue of convertible loan notes to existing and new investors in the Company. The proceeds of the Fundraising will be used to provide additional working capital to minimise any potential supply chain disruption to the delivery of contracts during the year.

The Loan Notes have a term of 18 months (with the Company having the option to extend the majority of the loan notes by three months), are senior in ranking and unsecured. The Loan Notes are convertible at investors option into ordinary shares in the capital of the Company (“Ordinary Shares”) at 15 pence per Ordinary Share, representing a 30% premium to the mid-price of the Company’s share price at close of business on 04 August 2022. The Loan Notes carry a coupon of 8% per annum and have a conversion date of 31 January 2024.

The Loan Note holders have the right to elect to be repaid in whole or in part in Ordinary Shares at the lower of the closing mid-market price on the repayment date, and 15 pence per share.

Based on a Fundraising of £1.7 million, the Loan Notes would, if converted at 15 pence per share, represent approximately 11.3 million Ordinary Shares, amounting to 2.6% of the current issued share capital of Kromek.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Kromek

More articles like this

Kromek

Kromek secures repeat order worth $0.8m

Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, has announced that it has secured a repeat order, worth $0.8m, from a US government customer for

Kromek

Kromek to enter new markets with expanded agreement

Sedgefield-based Kromek has expanded its distribution agreement with a global threat detection and security research company, which will allow it to enter new markets. Under the terms of the new agreement, Smiths Detection will market and

Kromek

Kromek wins two contracts for its nuclear security products

Developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, Kromek Group plc, has today announced that it has secured two contracts, totalling £1.5 million, for the supply of its D3M

Kromek

Kromek expands agreement with Smiths Detection

Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, is pleased to announce that it has entered into a distribution agreement with Smiths Detection, a

Kromek

Kromek announces £1.5m contracts with European government bodies

North East technology firm Kromek has announced contracts totalling £1.5m for the supply of radiation detectors to two European governmental bodies. The County Durham firm, which develops and manufactures radiation and bio-detection technology solutions, is supplying

Kromek

Kromek secures two new contracts totalling £1.5m

Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, has announced that it has secured two contracts, totalling £1.5m, for the supply of its D3M and D3S-based

Kromek

Contract win as market for radiation detection technology grows

Radiation and bio-detection technology firm, Kromek, has delivered a contract worth $1.3m/£1.1m for a US customer. Huddersfield-based Kromek is supplying the client with its D3M wearable radiation detector. This contract is a repeat order, with Kromek

Kromek

Kromek secures £5m contract with a UK Government department

Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, has announced that it has secured a contract with a UK Government department to develop and supply biological

Kromek

Kromek presents at the NATO TIDE Sprint #40 event

Kromek, the County Durham-based developer and manufacturer of biological and radiological detection equipment, presented a paper at the Fall 2022 NATO TIDE Sprint #40 symposium being held from 24-28 October 2022 in Virginia Beach, USA. TIDE is the NATO

Kromek

The AARM – Survey large areas safely

Got a project in mind? So you need to complete a widespread environmental survey, get the go ahead for a mining or infrastructure development project. Maybe you need to plan your next steps in decommissioning a

Kromek

Kromek returns to the Counter Threat Symposium 2022

Kromek, the County Durham-based developer and manufacturer of biological and radiological detection equipment, will be exhibiting at the Counter Threat Symposium 2022 at the Farnborough International Exhibition and Conference Centre, stand 5, from 8-10 November 2022.

Kromek

Spectrum Dynamics integrates CZT detectors in VERITON-CT 400 series

Spectrum Dynamics Medical has integrated cadmium zinc telluride (CZT) detectors from Kromek Group in its digital SPECT/CT products called the VERITON-CT 400 series. CZT is a room-temperature semiconductor, which directly transforms x-ray or gamma photons into electrons and holes. It is